Exendin-4: A Potent GLP-1 Receptor Agonist for Advanced Research and Pharmaceutical Development

Discover Exendin-4 (CAS 141758-74-9), a leading GLP-1 receptor agonist critical for diabetes and metabolic research. As a trusted supplier, we offer high-purity Exendin-4 to accelerate your scientific breakthroughs. Get a quote today!

Get a Quote & Sample

Key Advantages of Sourcing Exendin-4

Exceptional Purity for Research Accuracy

Our Exendin-4 is characterized by exceptional purity, confirmed through rigorous HPLC analysis, guaranteeing the integrity of your research data. We provide COA and MSDS for every batch, ensuring full transparency for our clients.

Versatile Applications in Drug Discovery

From in vitro studies on insulin secretion to in vivo models for diabetes and obesity, Exendin-4 is a cornerstone reagent for drug discovery. Buy Exendin-4 to investigate novel therapeutic strategies.

Stable and Reliable Supply Chain

As a leading Exendin-4 manufacturer, we ensure a stable and reliable supply chain, meeting the demands of pharmaceutical companies and research institutions worldwide. Secure your supply with us.

Core Application Areas for Exendin-4

Diabetes Mellitus Research

Investigate the therapeutic potential of Exendin-4 in managing type 2 diabetes by understanding its role in insulin secretion and glucose homeostasis. Purchase Exendin-4 for your diabetes research projects.

Obesity and Metabolic Syndrome

Explore Exendin-4's impact on appetite regulation and weight management, crucial for addressing the growing challenges of obesity. Learn how our peptides can support obesity research.

Neuroprotection Studies

Exendin-4 has shown promise in protecting neurons from excitotoxicity, making it valuable for neurodegenerative disease research. Buy Exendin-4 to explore its neuroprotective mechanisms.

Drug Development and Screening

Utilize Exendin-4 as a benchmark compound in the development of new incretin mimetics and therapeutic agents. We are your go-to supplier for Exendin-4 for pharmaceutical development.